Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as ...

D illustration of Clostridium scindens in the intestine. Credit: K. Schoonjans (EPFL) EPFL scientists have uncovered how a ...

Sometimes there are clear triggers, but often no clear cause can be found.” Irritable bowel syndrome is a disorder of the ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

Numerous studies have looked at the effect of probiotics on this most common form of eczema. Overall, the evidence suggests ...

Inflammatory bowel disease is a diverse disease that affects people all over the globe. This diversity in setting and treatment options makes it difficult for researchers to estimate the exact cost of ...

Positive preliminary data from all five single ascending dose (SAD) cohorts and first three completed multiple ascending dose (MAD) cohorts ...

Palisade Bio (PALI) provided an update on its ongoing Phase 1a/b study of PALI-2108 for the treatment of Ulcerative Colitis, UC. The Company ...

HOUSE, PA — Johnson & Johnson (NYSE: JNJ) announced promising topline data from its Phase 2b ANTHEM-UC clinical trial evaluating icotrokinra (JNJ-2113) as a treatment for moderately to severely active ...

IBD affects millions of Americans. It's estimated that 130,000 adults and children in New England are living with the disease ...

A new study reveals that Epstein-Barr virus (EBV) infection exacerbates ulcerative colitis (UC) by driving macrophage ...